Agilent Technologies (FRA:AG8) 3-Year Revenue Growth Rate : 10.50% (As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Agilent Technologies 3-Year Revenue Growth Rate?

Agilent Technologies's Revenue per Share for the three months ended in Jan. 2024 was €5.18.

During the past 12 months, Agilent Technologies's average Revenue per Share Growth Rate was -1.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Agilent Technologies was 18.40% per year. The lowest was -22.90% per year. And the median was 4.90% per year.

Competitive Comparison of Agilent Technologies's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Agilent Technologies's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Agilent Technologies's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's 3-Year Revenue Growth Rate falls into.

Agilent Technologies 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Agilent Technologies (FRA:AG8) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Agilent Technologies 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilent Technologies (FRA:AG8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (FRA:AG8) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

A:USA A:Mexico 1A:Italy AG8:Germany

Address

5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051

Website

https://www.agilent.com

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Agilent Technologies (FRA:AG8) Headlines

No Headlines